Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
NewsAs health insurance costs climb and coverage shrinks, Americans are turning to flat-fee prescription drug subscriptions from Amazon and GoodRx. Amazon's RxPass ($5/month) and GoodRx's Companion plan ($14.99/month) offer access to generic drugs and other health services. Analysts say these plans are becoming a practical complement — or even alternative — to traditional insurance, especially for those on multiple medications.
With health insurance premiums rising and millions of Americans dropping ACA plans in 2026, companies like Amazon and GoodRx are stepping in with affordable prescription drug subscription services. Amazon's RxPass, available to Prime members for just $5/month, covers around 50 generic drugs, while GoodRx's Companion plan at $14.99/month offers over 250 generics plus discounts on telehealth, dental, vision, and lab services. Employer-sponsored insurance costs are projected to rise up to 11% in 2027, making these flat-fee options increasingly attractive.
The demand is real — and growing. Amazon says RxPass usage has nearly tripled since its 2023 launch, with over 70% of users filling three or more medications. GoodRx reported a 39% year-over-year jump in subscription revenue, hitting $28.5 million in Q2. Other players like FreeRx and Mark Cuban's Cost Plus Drugs are also competing for cost-conscious consumers.
By the Numbers:
Why it matters: As traditional insurance becomes less accessible and more expensive, subscription-based drug plans are emerging as a meaningful safety net for Americans managing chronic conditions — reshaping how consumers access and pay for medications.